Health Care & Life Sciences » Pharmaceuticals | Guangdong Taiantang Pharmaceutical Co. Ltd.

Guangdong Taiantang Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
779
1,220
2,362
3,049
3,200
3,276
Cost of Goods Sold (COGS) incl. D&A
478
796
1,729
2,272
2,315
2,445
Gross Income
301
424
633
777
885
830
SG&A Expense
135
188
399
449
489
642
EBIT
163
224
225
328
396
188
Unusual Expense
1
7
-
-
1
-
Non Operating Income/Expense
2
225
2
22
48
209
Interest Expense
15
22
16
61
94
133
Pretax Income
156
208
222
295
354
333
Income Tax
19
15
27
42
60
53
Consolidated Net Income
137
192
196
253
294
275
Net Income
133
186
190
243
290
271
Net Income After Extraordinaries
133
186
190
243
290
271
Net Income Available to Common
133
186
190
243
290
271
EPS (Basic)
0.24
0.30
0.26
0.32
0.38
0.35
Basic Shares Outstanding
556
621
731
771
769
767
EPS (Diluted)
0.24
0.30
0.26
0.31
0.32
0.35
Diluted Shares Outstanding
556
621
731
785
907
767
EBITDA
201
276
282
396
480
277
Other Operating Expense
-
3
11
10
-
-
Non-Operating Interest Income
5
9
10
4
2
70
Minority Interest Expense
4
6
5
10
4
4

About Guangdong Taiantang Pharmaceutical Co.

View Profile
Address
Kirin Park
Shantou Guangdong 515021
China
Employees -
Website http://www.taiantang.net
Updated 07/08/2019
Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the development, production, and sale of chinese medicines. Its products include inside and outside chinese medicine for skin, infertility drugs, cardiovascular drugs, and drugs for children. The company was founded in 1995 and is headquartered in Shantou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.